Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Sorafenib × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 5 Leukemia, Myeloid, Acute 2 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Locally Advanced Thyroid Gland Carcinoma 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Temozolomide 13 Irinotecan 10 Cyclophosphamide 8 naxitamab 7 dinutuximab 6 sargramostim 5 Vincristine 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Melphalan 4 Eflornithine 4 Carboplatin 4 fludarabine 3 Zoledronic Acid 3 Etoposide 3 Doxorubicin 3 saponin QA-21V1 2 lutetium Lu 177 dotatate 2 etoposide phosphate 2 aldesleukin 2 Topotecan 2 Thiotepa 2 Specimen Handling 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Colony-Stimulating Factors 2 Cisplatin 2 Busulfan 2 3-fluorobenzylguanidine 2 3-Iodobenzylguanidine 2 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02559778 2026-02-20

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡